Cargando…

Prostate Cancer—PET Imaging Update

SIMPLE SUMMARY: The imaging of prostate cancer has evolved over the last few decades with molecular imaging, especially Positron Emission Tomography (PET) replacing conventional CT and MRI in patients with prostate cancer recurrence. These recent advances in PET imaging have allowed for a better loc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jetty, Sankarsh, Loftus, James Ryan, Patel, Abhinav, Gupta, Akshya, Puri, Savita, Dogra, Vikram
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913636/ https://www.ncbi.nlm.nih.gov/pubmed/36765754 http://dx.doi.org/10.3390/cancers15030796

Ejemplares similares

Multimodality imaging of neurodegenerative disorders with a focus on multiparametric magnetic resonance and molecular imaging
por: Loftus, James Ryan, et al.
Publicado: (2023)

Clinical Significance of T2*gradient-recalled Echo/susceptibility-weighted Imaging Sequences in Evaluating Superficial Siderosis in the Setting of Intracerebral Tumors: Pilocytic Astrocytoma
por: Jetty, Sankarsh N., et al.
Publicado: (2018)

PET Imaging in Bladder Cancer: An Update and Future Direction
por: Zhang-Yin, Jules, et al.
Publicado: (2023)

The Use of MRI and PET Imaging Studies for Prostate Cancer Management: Brief Update, Clinical Recommendations, and Technological Limitations
por: Mansbridge, Margaret, et al.
Publicado: (2019)

PET-CT and PET-MR in urological cancers other than prostate cancer: An update on state of the art
por: Razik, Abdul, et al.
Publicado: (2018)

Update on PET Radiopharmaceuticals for Imaging Hepatocellular Carcinoma
por: Nyakale, Nozipho, et al.
Publicado: (2023)

FAPI PET/CT Imaging—An Updated Review
por: Chandekar, Kunal Ramesh, et al.
Publicado: (2023)

Molecular Research in Urology 2014: Update on PET/MR Imaging of the Prostate
por: Wetter, Axel
Publicado: (2014)

Multimodality imaging of renal lymphoma and its mimics
por: Nguyen, Trinh, et al.
Publicado: (2022)

Clinical practice in prostate PET imaging
por: Huls, Sean J., et al.
Publicado: (2023)

Statin Use in Prostate Cancer: An Update
por: Babcook, Melissa A., et al.
Publicado: (2016)

Folate-Based Radiotracers for PET Imaging—Update and Perspectives
por: Müller, Cristina
Publicado: (2013)

PET/CT imaging in prostate cancer
por: Barwick, Tara
Publicado: (2015)

PSMA PET in Imaging Prostate Cancer
por: Tsechelidis, Ioannis, et al.
Publicado: (2022)

New prospects for PET in prostate cancer imaging: a physicist's viewpoint
por: Conti, Maurizio
Publicado: (2014)

The Performance of FDA-Approved PET Imaging Agents in the Detection of Prostate Cancer
por: Li, Mei, et al.
Publicado: (2022)

(18)F-fluorothymidine PET imaging in gliomas: an update
por: Nikaki, Alexandra, et al.
Publicado: (2017)

(18)F-PSMA-1007 PET in Biochemical Recurrent Prostate Cancer: An Updated Meta-Analysis
por: Ferrari, Matteo, et al.
Publicado: (2021)

An Update on [(18)F]Fluoride PET Imaging for Atherosclerotic Disease
por: Lee, Reeree, et al.
Publicado: (2020)

Lymph node imaging in initial staging of prostate cancer: An overview and update
por: Zarzour, Jessica G, et al.
Publicado: (2017)

Review of Gallium-68 PSMA PET/CT Imaging in the Management of Prostate Cancer
por: Lenzo, Nat P., et al.
Publicado: (2018)

Present and future roles of FDG-PET/CT imaging in the management of gastrointestinal cancer: an update
por: Kitajima, Kazuhiro, et al.
Publicado: (2017)

Cardiac PET/MRI—an update
por: Rischpler, C., et al.
Publicado: (2019)

Prostate MRI and PSMA-PET in the Primary Diagnosis of Prostate Cancer
por: Cereser, Lorenzo, et al.
Publicado: (2023)

Choline PET and PET/CT in Primary Diagnosis and Staging of Prostate Cancer
por: Schwarzenböck, S., et al.
Publicado: (2012)

PET/CT and Conventional Imaging for the Assessment of Neuroendocrine Prostate Cancer: A Systematic Review
por: Dondi, Francesco, et al.
Publicado: (2023)

Role of PET imaging for biochemical recurrence following primary treatment for prostate cancer
por: Galgano, Samuel J., et al.
Publicado: (2018)

Development of Antibody Immuno-PET/SPECT Radiopharmaceuticals for Imaging of Oncological Disorders—An Update
por: Dewulf, Jonatan, et al.
Publicado: (2020)

PET Imaging in Neuro-Oncology: An Update and Overview of a Rapidly Growing Area
por: Verger, Antoine, et al.
Publicado: (2022)

PSMA PET imaging in the diagnosis and management of prostate cancer
por: Houshmand, Sina, et al.
Publicado: (2023)

Angiogenesis Inhibition in Prostate Cancer: An Update
por: Sarkar, Chandrani, et al.
Publicado: (2020)

Genetic predisposition to prostate cancer: an update
por: Ni Raghallaigh, Holly, et al.
Publicado: (2021)

Defining Oligometastatic Disease in the New Era of PSMA-PET Imaging for Primary Staging of Prostate Cancer
por: Galgano, Samuel J., et al.
Publicado: (2022)

Multiparametric magnetic resonance imaging for prostate cancer: A review and update for urologists
por: Yoo, Sangjun, et al.
Publicado: (2015)

Prostate-Specific Membrane Antigen PET Imaging in Prostate Cancer: Opportunities and Challenges
por: Oh, So Won, et al.
Publicado: (2018)

[(18)F] Sodium Fluoride PET Kinetic Parameters in Bone Imaging
por: Puri, Tanuj, et al.
Publicado: (2021)

Traditional and novel imaging modalities for advanced prostate cancer: A critical review
por: Hill, Spencer, et al.
Publicado: (2023)

FDG-PET Imaging for Hodgkin and Diffuse Large B-Cell Lymphoma—An Updated Overview
por: Voltin, Conrad-Amadeus, et al.
Publicado: (2020)

The Continuum of Metastatic Prostate Cancer: Interpreting PSMA PET Findings in Recurrent Prostate Cancer
por: Kase, Adam M., et al.
Publicado: (2022)

Multispectral Photoacoustic Imaging of Prostate Cancer: Preliminary Ex-vivo Results
por: Dogra, Vikram S., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_h6e2o0cvc2laakiugil0pe3smn